Showing results (191-200 of 418) with videos related to
Sort By:
Pageof 42
Arthritis Research & Therapy|November 12, 2014
Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulationJulia Sieber, Capucine Daridon, Sarah J Fleischer, et al.Journal of Clinical Pharmacology|September 8, 2016
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTAHisham Abdallah, Joy C Hsu, Peng Lu, et al.RMD Open|June 3, 2025
Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular diseaseGerd R Burmester, Eduardo Mysler, Peter Taylor, et al.European Journal of Immunology|July 7, 2018
Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursorsTobias Alexander, Qingyu Cheng, Jens Klotsche, et al.Journal of Biomedical Materials Research. Part B, Applied Biomaterials|December 23, 2003
Does low-intensity pulsed ultrasound stimulate maturation of tissue-engineered cartilage?Georg N Duda, Alexander Kliche, Ralf Kleemann, et al.Journal of Nanobiotechnology|May 29, 2019
Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytesChristien M Beez, Marion Haag, Oliver Klein, et al.Annals of the Rheumatic Diseases|March 12, 2018
Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)Désirée van der Heijde, David I Daikh, Neil Betteridge, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2018
Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR)Désirée van der Heijde, David I Daikh, Neil Betteridge, et al.Arthritis and Rheumatism|April 29, 2006
Tissue-specific up-regulation of the proteasome subunit beta5i (LMP7) in Sjögren's syndromeThomas Egerer, Lorena Martinez-Gamboa, Anja Dankof, et al.Arthritis Research & Therapy|March 13, 2012
The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expressionDaniela Frölich, Daniela Blassfeld, Karin Reiter, et al.Pageof 42